Efficacy of low-dose dopamine in preventing amphotericin B nephrotoxicity in bone marrow transplant patients and leukemia patients

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 12, 1998, Pages 3103-3106

  Camp, Mary J ^a,d   Wingard, John R ^b,e   Gilmore, Claire E ^a,f   Lin, Lillian S ^c   Dix, Suzanne P ^a,g   Davidson, Terry G ^a   Geller, Robert B ^b,g  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Univ of Florida Hlth Sci Center ^*  (United States)

^e UNIVERSITY OF FLORIDA HEALTH   (United States)

^f NORTHSIDE HOSPITAL   (United States)

^g St Lukes Hospital of Kansas City   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; DOPAMINE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION TEST; LEUKEMIA; MALE; MYCOSIS; NEPHROTOXICITY; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031787912     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.12.3103     Document Type: Article

References (11)

1. Armitage, P. 1955. Test for linear trends in proportions and frequencies. Biometrics 11:375-386.
2. Branch, R. A. 1988. Prevention of amphotericin B-induced renal impair-ment. Arch. Intern. Med. 148:2389-2394.
3. Branch, R. A., E. K. Jackson, and E. Jacqz. 1987. Amphotericin B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline. Klin. Wochenschr. 65:500-506.
4. Gardner, M., P. Godley, and S. Wasan. 1990. Sodium loading treatment for amphotericin B-induced nephrotoxicity. DICP Ann. Pharmacother. 24:940-946.
5. Heidemann, H., J. Gerkens, W. A. Spickard, E. Jackson, and R. Branch. 1983. Amphotericin B nephrotoxicity in humans decreased by salt repletion. Am. J. Med. 75:476-481.
6. Mantel, N. 1966. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50:163-170.
7. Medoff, G., and G. S. Kobayashi. 1980. Strategies in the treatment of systemic fungal infections. N. Engl. J. Med. 14:177-181.
8. Sabra, R., and R. A. Branch. 1990. Amphotericin B nephrotoxicity. Drug Saf. 5:94-108.
9. Saral, R. 1991. Candida and aspergillus infections in immunocompromised patients: an overview. Rev. Infect. Dis. 13:487-492.
10. Schwartz, L., and B. Gewertz. 1988. The renal response to low dose dopamine. J. Surg. Res. 45:574-588.
11. Stein, R. S., K. Albridge, R. K. Lenox, R. Ray, and J. M. Fexner. 1988. Nephrotoxicity in leukemic patients receiving empirical amphotericin B and aminoglycosides. South. Med. J. 81:1095-1099.